fda on tirzepatide Wins Approval for Weight Loss FDA Approves Tirzepatide (Zepbound) as

Nu-U.Ai | Post GLP-1 forum & AI chatbot SaaS company profile on GetLatka revenue, ARR, valuation, funding rounds, customers, team size, and growth.

This Topic Guide brings together everything Peter has discussed across podcasts, AMAs, and writing to help you understand how GLP-1 agonists work, what the evidence actually shows, and how to reason clearly about their roleif anyin a sustainable, long-term approach to health.

GLP-1 medications require medical review and are not appropriate for everyone

This list may not include every possible side effect.It is absolutely essential to have a thorough discussion with your healthcare provider about your personal health history and all potential risks and benefits *before* starting Zepbound

NO contracts and NO start up fees.

list price as of April 2026 (investigational published pricing)